Orchestra BioMed Holdings, Inc.·4

Jul 24, 5:12 PM ET

Taylor Andrew Lawrence 4

4 · Orchestra BioMed Holdings, Inc. · Filed Jul 24, 2023

Insider Transaction Report

Form 4
Period: 2023-07-20
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.0001 per share ("Common Stock")

    2023-07-20+278,363278,363 total
Footnotes (1)
  • [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of June 6, 2023 (the "Vesting Commencement Date"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates.

Documents

1 file
  • 4
    tm2321855-8_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT